Last Updated: September 28, 2026

Leading Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for LEADING

LEADING has seventeen approved drugs.

Summary for Leading

US Patents:	0
Tradenames:	17
Ingredients:	17
NDAs:	17

Drugs and US Patents for Leading

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Leading	LORAZEPAM	lorazepam	TABLET;ORAL	078203-001	Jul 30, 2007	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Leading	PROCHLORPERAZINE MALEATE	prochlorperazine maleate	TABLET;ORAL	218912-002	Sep 30, 2024	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Leading	FROVATRIPTAN SUCCINATE	frovatriptan succinate	TABLET;ORAL	216998-001	Apr 16, 2025	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Leading	HYDROCHLOROTHIAZIDE	hydrochlorothiazide	TABLET;ORAL	040702-001	Mar 16, 2007	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Leading	BENZTROPINE MESYLATE	benztropine mesylate	TABLET;ORAL	090168-001	Nov 28, 2012	AA	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.